Background and Purpose-North Carolina is situated in the « stroke belt » region of the United States, an area of the country with a particularly high incidence of cerebrovascular disease.
The North Carolina Stroke Prevention and Treatment Facilities Survey was carried out to determine the availabilities of a variety of stroke prevention and treatment services throughout the state.
The purpose of the present study was to determine how widely recombinant tissue-type plasminogen activator (rtPA) has been adopted for the treatment of patients with acute ischemic stroke and to determine the characteristics of the medical facilities in the state offering this therapy.
Methods-A single-page survey was mailed to the medical center directors of each inpatient medical facility in North Carolina.
Data collected included questions related to the availability of selected basic and advanced diagnostic tests and procedures, stroke prevention and treatment programs and services (community stroke awareness program, acute stroke identification program, acute stroke team, stroke rtPA protocol, stroke care map, neurologist), and facilities (Stroke Acute Care Unit or equivalent).
Responses were obtained from all 125 inpatient medical facilities in North Carolina. rtPA stroke protocols were adopted in 54 facilities located in 46 of the state's 100 counties.
Seventy-four percent of the state's population resides in counties with hospitals providing rtPA treatment. (...)
Mots-clés Pascal : Accident cérébrovasculaire, Ischémie, Aigu, t-Plasminogen activator, Serine endopeptidases, Peptidases, Hydrolases, Enzyme, Protéine recombinante, Chimiothérapie, Fibrinolytique, Pratique professionnelle, Utilisation, Programme sanitaire, Caroline du Nord, Etats Unis, Amérique du Nord, Amérique, Equipement collectif, Service urgence, Evaluation, Traitement, Homme, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Cérébrovasculaire pathologie, Appareil circulatoire pathologie, Vaisseau sanguin pathologie
Mots-clés Pascal anglais : Stroke, Ischemia, Acute, t-Plasminogen activator, Serine endopeptidases, Peptidases, Hydrolases, Enzyme, Recombinant protein, Chemotherapy, Fibrinolytic, Professional practice, Use, Sanitary program, North Carolina, United States, North America, America, Facility, Emergency department, Evaluation, Treatment, Human, Nervous system diseases, Central nervous system disease, Cerebral disorder, Cerebrovascular disease, Cardiovascular disease, Vascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0505790
Code Inist : 002B02G. Création : 19/02/1999.